Jingjing Zhu

机构：Ludwig Cancer Research, Chinese Academy of Medical Sciences & Peking Union Medical College, de Duve Institute · ORCID：0000-0003-0993-4849

发表论文 231 篇 · 总被引 4126 次 · h-index 35

代表论文

• Antibody-drug conjugates for targeted cancer therapy: Recent advances in potential payloads (2024 · European Journal of Medicinal Chemistry · 被引 44)
• A low-cost bio-based cellulose composite hydrogel with cross-linked structures for efficient capture of heavy metal ions (2024 · Separation and Purification Technology · 被引 34)
• Enhanced tumor response to adoptive T cell therapy with PHD2/3-deficient CD8 T cells (2024 · Nature Communications · 被引 14)
• Unlocking the mystery of the PD-1/PD-L1 axis: beyond the checkpoint hype (2025 · Frontiers in Immunology · 被引 7)
• Isoliquiritigenin attenuates cisplatin-induced hearing loss and ototoxicity by activating the Keap1-Nrf2-ARE pathway (2025 · Free Radical Biology and Medicine · 被引 6)
• Sprayable MXene composited carboxymethyl cellulose/pectin hydrogel with photothermal enhanced antibacterial for full-thickness skin wound healing (2025 · Biomaterials Advances · 被引 5)